About the book
Asthma is a chronic inflammatory disease of the airways accompanied by variable bronchial hyperresponsiveness with heterogenic genetic and environment interplay. Despite recent advances in disease diagnostics and treatments, asthma is either under- or over-diagnosed and, therefore, often mistreated. The disease is on a rise worldwide currently affecting over 330 million people with around 1000 people dying of asthma each day.
This book will provide the latest understandings of the basics on cellular and molecular mechanisms of asthma, an overview of current FDA-approved treatments, and how they work. In addition to Th2-type allergic asthma, its subtypes and distinctions in treatment options, this book provides recent updates on non-Th2-type or mixed-type asthma such as occupational, medication-induced, and exercise-provoked asthma. New genomics and proteomics technologies help to improve our understanding of the important undelaying pathways and to facilitate novel therapeutic and immunomodulatory agents. The future perspectives in disease prevention and treatment will also be analyzed and discussed.